As highlighted...not like the rest that are 'exploring'...these guys already in discussions!
ADVENTRX Pharmaceuticals, Inc. (Amex: ANX - News), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer, today announced that it is exploring a range of strategic options, including the sale or disposition of one or more of its product candidate programs, a strategic business merger and other transactions that maximize the value of Company's assets. The Company is currently in discussions with several candidates for both strategic and partnering transactions.